 | • レポートコード：TPM-C03070 • 出版社/出版日：Transparency Market Research / 2019年2月6日 • レポート形態：英文、PDF、251ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Global Site License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、オーソバイオロジクスの世界市場について調べ、オーソバイオロジクスの世界規模、市場動向、市場環境、製品別（骨形成タンパク質、脱灰骨基質、合成骨移植代用品、粘性補充剤、同種移植片、幹細胞）分析、用途別（脊椎固定、外傷修復、再建手術）分析、エンドユーザー別（病院、整形外科医院）分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、関連企業情報などをまとめた調査レポートです。 ・序文・調査範囲・調査手法 ・エグゼクティブサマリー ・オーソバイオロジクスの世界市場動向 ・オーソバイオロジクスの世界市場環境 ・オーソバイオロジクスの世界市場規模 ・オーソバイオロジクスの世界市場規模：製品別（骨形成タンパク質、脱灰骨基質、合成骨移植代用品、粘性補充剤、同種移植片、幹細胞） ・オーソバイオロジクスの世界市場規模：用途別（脊椎固定、外傷修復、再建手術） ・オーソバイオロジクスの世界市場規模：エンドユーザー別（病院、整形外科医院） ・オーソバイオロジクスの世界市場：地域別市場規模・分析 ・オーソバイオロジクスの北米市場規模・予測 ・オーソバイオロジクスのアメリカ市場規模・予測 ・オーソバイオロジクスの中南米市場規模・予測 ・オーソバイオロジクスのヨーロッパ市場規模・予測 ・オーソバイオロジクスのアジア市場規模・予測 ・オーソバイオロジクスの日本市場規模・予測 ・オーソバイオロジクスの中国市場規模・予測 ・オーソバイオロジクスのインド市場規模・予測 ・オーソバイオロジクスの中東市場規模・予測 ・オーソバイオロジクスのアフリカ市場規模・予測 ・競争状況・関連企業情報 |
Global Orthobiologics Market: Overview
This report analyzes the current and future scenario of the global orthobiologics market. Surge in the number of orthopedic procedures, increase in demand for biologics in spinal surgery and traumatic injuries, and rise in prevalence of chronic arthritis are projected to drive the global market. Additionally, rise in prevalence of sports injuries propels the global orthobiologics market.
This report comprises an elaborate executive summary, which includes information about various segments of the global orthobiologics market. It also provides information and data analysis of the global market with respect to the segments based on product, application, end-user, and region. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the overview section. Additionally, the section comprises competitive matrix and company profiles along with business overview to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis by region and market share analysis by key players, thereby presenting a thorough analysis of the overall competitive scenario in the global orthobiologics market.
Global Orthobiologics Market: Key Segments
In terms of product, the global orthobiologics market has been segmented into bone morphogenetic proteins, demineralized bone matrix, synthetic bone substitutes, viscosupplements, allografts, stem cell, and others. Based on application, the global market has been classified into spinal fusion, trauma repair, reconstructive surgeries, and others. In terms of end-user, the global orthobiologics market has been segmented into hospitals, orthopedic clinics, and others. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.
Global Orthobiologics Market: Regional Outlook
In terms of region, the global orthobiologics market has been segmented into North America (the U.S. and Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, China, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (South Africa, GCC Countries, and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries/sub-regions have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year. The research study also covers the competitive scenario in these regions.
Companies Mentioned in Report
The report also profiles major players in the global orthobiologics market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major players profiled in the report include Medtronic, DePuy Synthes (Johnson & Johnson), Sanofi, Seikagaku Corporation, Stryker, MTF Biologics, Bioventus, Arthrex, Zimmer Biomet, RTI Surgical, Inc., Alphatec Spine, Inc., Exactech, Inc., Globus Medical, Inc., and Integra LifeSciences.
The global orthobiologics market has been segmented as below:
Global Orthobiologics Market, by Product
Bone Morphogenetic Proteins
Demineralized Bone Matrix
Synthetic Bone Substitutes
Viscosupplements
Allografts
Stem cell
Others
Global Orthobiologics Market, by Application
Spinal Fusion
Trauma Repair
Reconstructive Surgeries
Others
Global Orthobiologics Market, by End-user
Hospitals
Orthopedic Clinics
Others
Global Orthobiologics Market, by Region
North America
U.S.
Canada
Europe
Germany
U.K.
Italy
France
Spain
Rest of Europe
Asia Pacific
India
China
Japan
Australia & New Zealand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Israel
Rest of Middle East & Africa
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Orthobiologics Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.1.1 Rise in Prevalence of Chronic Arthritis
4.3.1.2 Surge in Sports Injuries
4.3.1.3 Demand for Innovative Product
4.3.2. Restraints
4.3.2.1 Lack of Reimbursement
4.3.2.2 Stringent Regulatory Requirement
4.3.3. Opportunities
4.3.3.1 Increase in focus on stem cell based matrices
4.3.3.2 Launch of new products and acquisition in emerging markets
4.4. Global Orthobiologics Market Analysis and Forecast, 2016–2026
5. Key Insights
5.1.Key Market Trends
5.2. Merger and Acquisition
5.3 Strategies of Top Five Players Operating in the Market
5.4 Incidence of Orthopedic Disorder, by Key Countries
5.5. Regulatory and Reimbursement Scenario, by Key Countries
6. Global Orthobiologics Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Market Value Forecast, by Product, 2016–2026
6.2.1. Demineralized Bone Matrix
6.2.2. Allografts
6.2.3. Synthetic Bone Substitutes
6.2.4. Viscosupplements
6.2.5. Bone Morphogenetic Proteins
6.2.6. Stem Cell Therapy
6.2.7. Others
6.4. Market Attractiveness, by Product
7. Global Orthobiologics Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Market Value Forecast, by Application, 2016–2026
7.2.1. Spinal Fusion
7.2.2. Trauma Repair
7.2.3. Reconstructive Surgeries
7.2.4. Others
7.3. Market Attractiveness, by Application
8. Global Orthobiologics Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Market Value Forecast, by End-user, 2016–2026
8.2.1. Hospitals
8.2.2. Orthopedic Clinics
8.2.3. Others
8.3. Market Attractiveness, by End-user
9. Global Orthobiologics Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness, by Country/Region
10. North America Orthobiologics Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product, 2016–2026
10.2.1. Demineralized Bone Matrix
10.2.2. Allografts
10.2.3. Synthetic Bone Substitutes
10.2.4. Viscosupplements
10.2.5. Bone Morphogenetic Proteins
10.2.6. Stem Cell Therapy
10.2.7. Others
10.3. Market Value Forecast, by Application, 2016–2026
10.3.1. Spinal Fusion
10.3.2. Trauma Repair
10.3.3. Reconstructive Surgeries
10.3.4. Others
10.4. Market Value Forecast, by End-user, 2016–2026
10.4.1. Hospitals
10.4.2. Orthopedic Clinics
10.4.3. Others
10.5. Market Value Forecast, by Country, 2016–2026
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe Orthobiologics Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product, 2016–2026
11.2.1. Demineralized Bone Matrix
11.2.2. Allografts
11.2.3. Synthetic Bone Substitutes
11.2.4. Viscosupplements
11.2.5. Bone Morphogenetic Proteins
11.2.6. Stem Cell Therapy
11.2.7. Others
11.3. Market Value Forecast, by Application, 2016–2026
11.3.1. Spinal Fusion
11.3.2. Trauma Repair
11.3.3. Reconstructive Surgeries
11.3.4. Others
11.4. Market Value Forecast, by End-user, 2016–2026
11.4.1. Hospitals
11.4.2. Orthopedic Clinics
11.4.3. Others
11.5. Market Value Forecast, by Country/Sub-region, 2016–2026
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Product
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Orthobiologics Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product , 2016–2026
12.2.1. Demineralized Bone Matrix
12.2.2. Allografts
12.2.3. Synthetic Bone Substitutes
12.2.4. Viscosupplements
12.2.5. Bone Morphogenetic Proteins
12.2.6. Stem Cell Therapy
12.2.7. Others
12.3. Market Value Forecast, by Application, 2016–2026
12.3.1. Spinal Fusion
12.3.2. Trauma Repair
12.3.3. Reconstructive Surgeries
12.3.4. Others
12.4. Market Value Forecast, by End-user, 2016–2026
12.4.1. Hospitals
12.4.2. Orthopedic Clinics
12.4.3. Others
12.5. Market Value Forecast, by Country/Sub-region, 2016–2026
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Product
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Orthobiologics Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product, 2016–2026
13.2.1. Demineralized Bone Matrix
13.2.2. Allografts
13.2.3. Synthetic Bone Substitutes
13.2.4. Viscosupplements
13.2.5. Bone Morphogenetic Proteins
13.2.6. Stem Cell Therapy
13.2.7. Others
13.3. Market Value Forecast, by Application, 2016–2026
13.3.1. Spinal Fusion
13.3.2. Trauma Repair
13.3.3. Reconstructive Surgeries
13.3.4. Others
13.4. Market Value Forecast, by End-user, 2016–2026
13.4.1. Hospitals
13.4.2. Orthopedic Clinics
13.4.3. Others
13.5. Market Value Forecast, by Country/Sub-region, 2016–2026
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Product
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Orthobiologics Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product, 2016–2026
14.2.1. Demineralized Bone Matrix
14.2.2. Allografts
14.2.3. Synthetic Bone Substitutes
14.2.4. Viscosupplements
14.2.5. Bone Morphogenetic Proteins
14.2.6. Stem Cell Therapy
14.2.7. Others
14.3. Market Value Forecast, by Application, 2016–2026
14.3.1. Spinal Fusion
14.3.2. Trauma Repair
14.3.3. Reconstructive Surgeries
14.3.4. Others
14.4. Market Value Forecast, by End-user, 2016–2026
14.4.1. Hospitals
14.4.2. Orthopedic Clinics
14.4.3. Others
14.5. Market Value Forecast, by Country/Sub-region, 2016–2026
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Product
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Global Orthobiologics Market Analysis, by Top Company Ranking, 2017
15.2. Global Orthobiologics Market Position Analysis, by Company
15.3. Company Profiles
15.3.1. Medtronic
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 SWOT Analysis
15.3.1.4 Financial Overview
15.3.1.5 Strategic Overview
15.3.2. DePuy Synthes (Johnson & Johnson)
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 SWOT Analysis
15.3.2.4 Financial Overview
15.3.2.5 Strategic Overview
15.3.3. Sanofi
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 SWOT Analysis
15.3.3.4 Financial Overview
15.3.4. Seikagaku Corporation
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 SWOT Analysis
15.3.4.4 Financial Overview
15.3.4.5 Strategic Overview
15.3.5. Stryker
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 SWOT Analysis
15.3.5.4 Financial Overview
15.3.5.5 Strategic Overview
15.3.6. MTF Biologics
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 SWOT Analysis
15.3.7. Bioventus LLC
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 SWOT Analysis
15.3.7.4 Strategic Overview
15.3.8. Arthrex
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 SWOT Analysis
15.3.8.4 Strategic Overview
15.3.9. Zimmer Biomet
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 SWOT Analysis
15.3.9.4 Financial Overview
15.3.9.5 Strategic Overview
15.3.10 RTI Surgical, Inc.
15.3.10.1 Company Overview
15.2.10.2 Product Portfolio
15.2.10.3 SWOT Analysis
15.2.10.4 Financial Overview
15.3.10.5 Strategic Overview
15.3.11. Alphatec Spine, Inc.
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 SWOT Analysis
15.3.11.4 Financial Overview
15.3.11.5 Strategic Overview
15.3.12. Exactech, Inc.
15.3.12.1 Company Overview
15.3.12.2 Product Portfolio
15.3.12.3 SWOT Analysis
15.3.12.4 Financial Overview
15.3.12.5 Strategic Overview
15.3.13. Globus Medical, Inc.
15.3.13.1 Company Overview
15.3.13.2 Product Portfolio
15.3.13.3 SWOT Analysis
15.3.13.5 Financial Overview
15.3.13.6 Strategic Overview
15.3.14. Integra LifeSciences
15.3.14.1 Company Overview
15.3.14.2 Product Portfolio
15.3.14.3 SWOT Analysis
15.3.14.4 Financial Overview
15.3.14.5 Strategic Overview
Table 01: Global Orthobiologics Market Size (US$ Mn) Forecast, by Product, 2016–2026
Table 02: Global Orthobiologics Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 03: Global Orthobiologics Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 04: Global Orthobiologics Market Size (US$ Mn) Forecast, by Region, 2016–2026
Table 05: North America Orthobiologics Market Size (US$ Mn) Forecast, by Country, 2016–2026
Table 06: North America Orthobiologics Market Size (US$ Mn) Forecast, by Product, 2016–2026
Table 07: North America Orthobiologics Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 08: North America Orthobiologics Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 09: Europe Orthobiologics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 10: Europe Orthobiologics Market Size (US$ Mn) Forecast, by Product, 2016–2026
Table 11: Europe Orthobiologics Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 12: Europe Orthobiologics Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 13: Asia Pacific Orthobiologics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 14: Asia Pacific Orthobiologics Market Size (US$ Mn) Forecast, by Product, 2016–2026
Table 15: Asia Pacific Orthobiologics Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 16: Asia Pacific Orthobiologics Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 17: Latin America Orthobiologics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 18: Latin America Orthobiologics Market Size (US$ Mn) Forecast, by Product, 2016–2026
Table 19: Latin America Orthobiologics Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 20: Latin America Orthobiologics Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 21: Middle East & Africa Orthobiologics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 22: Middle East & Africa Orthobiologics Market Size (US$ Mn) Forecast, by Product, 2016–2026
Table 23: Middle East & Africa Orthobiologics Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 24: Middle East & Africa Orthobiologics Market Size (US$ Mn) Forecast, by End-user, 2016–2026